SCHEMBL30822010

SCHEMBL30822010

Cc1ccc(N2CCOCC2)cc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.49
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 4/20 0.49
TP53 P04637 2/20 0.49
MAPK1 P28482 2/20 0.49
MEN1 O00255 2/20 0.49
HTT P42858 2/20 0.49
KMT2A Q03164 2/20 0.49
USP2 O75604 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
GAA P10253 2/20 0.48
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
PRKDC P78527 1/20 0.47
P2RX7 Q99572 1/20 0.46
LGMN Q99538 1/20 0.45
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12059104 1.00 MAPT (0.49) MAPTKDM4EALDH1A1TP53MAPK1
SCHEMBL12058926 0.87 MAPT (0.53) MAPTKDM4EALDH1A1TP53MAPK1
SCHEMBL13122994 0.85 AR (0.49) MAPTALDH1A1MAPK1MEN1HTT
SCHEMBL28166708 0.83 AR (0.48) MAPTALDH1A1MAPK1MEN1HTT
SCHEMBL21448004 0.82 SIRT6 (0.61) MAPTKDM4EALDH1A1MAPK1MEN1
SCHEMBL2012672 0.81 LGMN (0.61) MAPTKDM4EALDH1A1TP53MAPK1
SCHEMBL11627069 0.81 ADRB1 (0.65) MAPTALDH1A1HTR2CPDK2SOS1
SCHEMBL12335653 0.81 LGMN (0.45) MAPTKDM4EALDH1A1TP53MAPK1
SCHEMBL12058711 0.80 SOS1 (0.45) MAPTKDM4EALDH1A1TP53MAPK1
SCHEMBL12875600 0.80 MGLL (0.44) MAPTKDM4EALDH1A1TP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043439-A1 COMPOUNDS AS C5AR INHIBITORS KIRA PHARMACEUTICALS (SUZHOU) LTD. (CN) 2024-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043439-A1 COMPOUNDS AS C5AR INHIBITORS C5AR1, C5AR2, C3AR1 MAPT 4518/4885KDM4E 4189/4885ALDH1A1 3678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.